NCT02242266 - Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter

Enrollment

121

Participants

Timeline

Start Date

July 28, 2005

Primary Completion Date

June 4, 2006

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium low dose

inhalation powder, hard PE capsule

DRUG

Tiotropium medium dose

inhalation powder, hard PE capsule

DRUG

Spiriva® HandiHaler® high dose

Tiotropium inhalation powder, hard gelatine capsule

DRUG

Placebo via the blue HandiHaler®

oral inhalation via the blue HandiHaler®

DRUG

Placebo via the grey HandiHaler®

oral inhalation via the grey HandiHaler®